Skip to main content
SpringerLink
Log in

Nierenzellkarzinom

Stellenwert von Immuntherapie und Chemotherapie

  • Published:
Der Urologe B

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Atzpodien J, Körfer A, Franks CR, Poliwoda H, Kirchner H (1990) Home therapy with recombinant inter-leukin-2 and interferon-a2b in advanced human malignancies. Lancet 1: 1509–1512

    Article  Google Scholar 

  2. Fossa SD, Martinelli G, Otto U, Schneider G, Wander H, Oberling F, Bauer HF, Achtnicht U, Holdener EE (1992) Recombinant interferon aIfa-2a with or without vinblastine in metastatic renal cell carcinoma: results of a European multi-center phase III study. Ann Oncol 3: 301–309

    CAS  PubMed  Google Scholar 

  3. Galligioni E, Quaia M, Merlo A, Carbone A, Spada A, Favaro D, Santarosa M, Sacco C, Talamini R, Gruppo Oncologico Clinico Cooperativo del Nord-Est (1996) Adjuvant immunotherapy treatment of renal carcinoma patients with autologous tumor cells and bacillus Calette-Guèrin — Five-years results of a prospective randomized study. Cancer 77: 2560–2566

    Article  CAS  PubMed  Google Scholar 

  4. Kriegmair M, Oberneder R, Hofstetter A (1995) Interferon alpha and vinblastine versus medroxyprogesterone acetate in the treatment of metastatic renal cell carcinoma. Urology 45: 758–768

    Article  CAS  PubMed  Google Scholar 

  5. Mickisch G, Bier H, Bergler W, Bak M, Tschada R, Alken P (1990) P-170 glycoprotein, glutathione and associated enzymes in relation to chemoresistance of primary human renal cell carcinomas. Urol Int 45: 170–182

    Article  CAS  PubMed  Google Scholar 

  6. Tallberg T, Tykkä H (1986) Specific active immunotherapy in advanced renal cell carcinoma: a clinical longterm follow-up study. World J Urol 3: 234–241

    Article  Google Scholar 

  7. Yagoda A, Petrylak D, Thompson S (1993) Cytotoxic chemotherapy for advanced renal cell carcinoma. Urol Clin North Am 20: 303–321

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Urologische Klinik der Heinrich-Heine-Universität Düsseldorf, Germany

    B. J. Schmitz-Dräger, A. Anastasiadis & T. Ebert

Authors
  1. B. J. Schmitz-Dräger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Anastasiadis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Ebert
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmitz-Dräger, B.J., Anastasiadis, A. & Ebert, T. Nierenzellkarzinom. Der Urologe B 38, 385–391 (1998). https://doi.org/10.1007/s001310050222

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s001310050222

Search

Navigation